'SCA Pharma Reponds to COVID-19: A Blog Series'
COVID-19 has transformed the delivery of health care in ways many of us could not have imagined. But as the crisis continues and evolves, it’s important to learn from early lessons COVID-19 taught us.
In a series of blogs and videos, senior leaders at SCA Pharma address the pandemic’s impact on quality, operations, product demand, and overall customer service during these challenging times.
Racheal Adams is Director of Corporate Quality at SCA Pharma as well as a pharmacist herself. In the video below, she discusses how SCA Pharma has worked with regulatory agencies not only to minimize disruptions but also to maintain a focus on quality and patient care.
Click here to watch the video.
You can download our updated list of medications to treat COVID-19 here.
To see CEO Milton Boyer’s first installment of this series, in which he describes his priorities for bolstering supply chains and satisfying customer needs, click here.
SCA Pharma is an FDA 503B outsourcing facility providing the highest quality sterile admixtures and pre-filled syringes. SCA Pharma specializes in preparing sterile pharmaceuticals customized for hospital pharmacies and healthcare facilities nationwide.
Headquartered in Little Rock, Arkansas, SCA Pharma has two state-of-the-art production facilities in both Arkansas and Connecticut. For more information, contact email@example.com.
This post is related to:Admixture Compounding Services (503B Outsourcing Facilities)